Atlanta Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-216,539
| Closed | -$15.3M | – | 155 |
|
2017
Q2 | $15.3M | Sell |
216,539
-8,347
| -4% | -$591K | 0.09% | 135 |
|
2017
Q1 | $15.3M | Sell |
224,886
-389,652
| -63% | -$26.5M | 0.09% | 144 |
|
2016
Q4 | $44M | Sell |
614,538
-44,433
| -7% | -$3.18M | 0.28% | 87 |
|
2016
Q3 | $52.1M | Sell |
658,971
-76,458
| -10% | -$6.05M | 0.35% | 77 |
|
2016
Q2 | $61.3M | Buy |
735,429
+29,980
| +4% | +$2.5M | 0.41% | 74 |
|
2016
Q1 | $64.8M | Buy |
705,449
+45,581
| +7% | +$4.19M | 0.46% | 70 |
|
2015
Q4 | $66.8M | Sell |
659,868
-100,688
| -13% | -$10.2M | 0.49% | 69 |
|
2015
Q3 | $74.7M | Sell |
760,556
-487,153
| -39% | -$47.8M | 0.56% | 73 |
|
2015
Q2 | $146M | Sell |
1,247,709
-849,793
| -41% | -$99.5M | 0.99% | 33 |
|
2015
Q1 | $206M | Buy |
2,097,502
+73,274
| +4% | +$7.19M | 1.4% | 17 |
|
2014
Q4 | $191M | Sell |
2,024,228
-201,204
| -9% | -$19M | 1.31% | 20 |
|
2014
Q3 | $237M | Sell |
2,225,432
-331,396
| -13% | -$35.3M | 1.7% | 8 |
|
2014
Q2 | $212M | Sell |
2,556,828
-26,798
| -1% | -$2.22M | 1.45% | 16 |
|
2014
Q1 | $183M | Sell |
2,583,626
-123,116
| -5% | -$8.72M | 1.26% | 22 |
|
2013
Q4 | $203M | Sell |
2,706,742
-113,236
| -4% | -$8.51M | 1.33% | 17 |
|
2013
Q3 | $177M | Sell |
2,819,978
-76,500
| -3% | -$4.81M | 1.26% | 21 |
|
2013
Q2 | $148M | Buy |
+2,896,478
| New | +$148M | 1.13% | 27 |
|